Iwona Majkowska

Iwona Majkowska

Iwona Majkowska is a financial markets journalist at TS2.tech, specializing in stocks, artificial intelligence and technology. A graduate of the Warsaw School of Economics, she previously worked in equity research and financial analysis before focusing on market reporting. Her daily coverage helps investors follow major developments across U.S. and global markets. Follow Iwona Majkowska on Google News.

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

Banco Bradesco S.A. shares climbed Thursday as Brazil’s equity market bounced, drawing attention back to the bank’s BBDC4 preferred shares among local and foreign investors. Bradesco PN ended at R$17.67 on B3 after settling at R$17.26 yesterday. The stock moved between R$17.17 and R$17.75 through the day. Investing.com showed the 52-week range at R$15.25 to R$22.12, with the lender’s market cap close to R$186.78 billion.
11 June 2026
·
Bitmine’s BMNR Stock Gains After Preferred Sale Wraps, Ethereum Move Draws Eyes

Bitmine’s BMNR Stock Gains After Preferred Sale Wraps, Ethereum Move Draws Eyes

• Bitmine Immersion Technologies shares changed hands at $16.52, a 5.6% jump from the last close at $15.64. The stock moved between $15.36 and $16.56.• On June 10, the company said it issued 3.5 million shares of 9.50% Series A Perpetual Preferred Stock.• Its latest crypto update listed 5.54 million ETH held, putting Bitmine at 4.59% of Ethereum’s 120.7 million supply.
11 June 2026
··
Mortgage Rates Edge Close to 2026 Peak, Inflation Holds Pressure on U.S. Housing

Mortgage Rates Edge Close to 2026 Peak, Inflation Holds Pressure on U.S. Housing

Mortgage rates in the U.S. edged up again this week, moving closer to their highs from 2026. That’s more pressure for buyers dealing with high prices, persistent inflation, and few signs that the Federal Reserve is ready to cut rates. Freddie Mac on Thursday put the average 30-year fixed at 6.52% for the week ending June 11, versus 6.48% the week before. That’s just under the 6.53% seen two weeks back.
11 June 2026
·
Robinhood Shares Gain as HOOD IPO Underwriters Face Retail Pressure

Robinhood Shares Gain as HOOD IPO Underwriters Face Retail Pressure

Robinhood Markets shares closed up about 3% at $86.36 on Wednesday and traded higher early Thursday. The stock is getting new interest as the broker steps closer to Wall Street’s main deal flow. What matters to investors isn’t just another update on trading volumes: Robinhood Securities got approval to underwrite IPOs, moving beyond distributing stock allocations to its app users and into helping companies go public.
11 June 2026
··
Battalion Oil Shares Jump With Traders Looking to BATL on Iran Tension

Battalion Oil Shares Jump With Traders Looking to BATL on Iran Tension

Battalion Oil Corporation shares jumped Wednesday as traders hunted for gains in smaller U.S. energy names after a U.S.-Iran flare-up brought supply risk back in focus. BATL finished at $2.06, up 57.25%. The stock opened at $1.32 and touched $2.93 at the day’s high. Volume hit 199.66 million. Benzinga said shares tacked on another 16.44% to $2.40 in after-hours trading, but early Thursday numbers on Investing.com showed the rally getting pared back.
11 June 2026
·
Fermi (FRMI) Jumps After OpenAI Data Center Report; Project Matador Lease Bets Return

Fermi (FRMI) Jumps After OpenAI Data Center Report; Project Matador Lease Bets Return

Fermi Inc. shares surged 22.6% to finish at $6.89 on Wednesday. The stock ticked up to $6.91 in early trading Thursday as traders looked for signs that big AI clients could still lock in massive, power-heavy data center contracts. The move wasn’t driven by a Fermi deal itself. Instead, OpenAI is reportedly talking to lease a 10-gigawatt data center project in Ohio, with Nvidia possibly backing it financially. That report put Fermi’s Project Matador back in play for the “power is the bottleneck” crowd.
11 June 2026
··
Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up

Outlook Therapeutics shares surged Wednesday as the stock once again drew regulatory-timer trades after the company filed its newest FDA application for ONS-5010/LYTENAVA, its candidate for wet age-related macular degeneration. The stock was last quoted near $0.89, up about 26% from Tuesday's close, with shares trading between $0.6853 and $0.8999 and volume near 21.9 million shares.
10 June 2026
··
1 … 24 25 26 27 28 … 33
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.